Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Analyzing Value of Breast Density Change Predicting ENdocrine Therapy Response in Postmenopausal Women Taking Adjuvant ARomatase Inhibitor

NCT01765049 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01765049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01765049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Analyzing Value of Breast Density Change Predicting ENdocrine Therapy Response in Postmenopausal Women Taking Adjuvant ARomatase Inhibitor
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2013
Completion date
December 15, 2025
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

estrogen receptor positive breast cancer, invasive breast cancer